{
    "clinical_study": {
        "@rank": "153014", 
        "acronym": "Loop-NVPO", 
        "arm_group": [
            {
                "arm_group_label": "Dexamethasone and Ondansetron", 
                "arm_group_type": "Experimental", 
                "description": "Each patient will receive Dexamethasone and Ondansetron"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Each patient will receive placebo instead of Dexamethasone and Ondansetron"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators want to test if it is indicated to associate dexamethasone and ondansetron\n      in obese patients having bariatric surgery under total intra-venous closed-loop anesthesia."
        }, 
        "brief_title": "Dexamethasone and Ondansetron Versus Placebo for Postoperative Nausea and Vomiting", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Postoperative Nausea and Vomiting", 
        "condition_browse": {
            "mesh_term": [
                "Nausea", 
                "Vomiting", 
                "Postoperative Nausea and Vomiting"
            ]
        }, 
        "detailed_description": {
            "textblock": "Obese patients having bariatric surgery have frequently postoperative nausea and vomiting\n      (PONV). We want to test if it is indicated to associate dexamethasone and ondansetron in\n      obese patients having bariatric surgery under total intra-venous closed-loop anesthesia.\n\n      Two groups to be studied: one will receive 4 mg dexamethasone at the end of the anesthetic\n      induction and 4 mg ondansetron at the end of the surgical procedure, one will receive normal\n      saline.\n\n      One hundred twenty consecutive patients meeting the inclusion and exclusion criteria and who\n      give written informed consent to participate in the study will be randomly assigned to one\n      of two experimental groups using a 1:1 ratio.\n\n      Patients will be continuously monitored in the post anesthesia care unit (PACU) and the\n      medical floor for a total of 24 hours post operatively. Episodes of nausea, vomiting and\n      administration of rescue therapy for either nausea or vomiting will be recorded and time\n      stamped. In addition, severity of nausea will be evaluated by the patient using a standard\n      verbal response scale (VRS) ranging from 0-10, 0 being no nausea and 10 being severe nausea.\n      Rescue therapy for PONV episodes will consist of 4 mg ondansetron followed by 0.625 mg\n      droperidol if necessary."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult patients aged 18-75 years\n\n          -  Scheduled for bariatric surgery under total intra-venous closed-loop anesthesia\n\n          -  Apfel score equal or greater than 2\n\n          -  Consenting to participate in the study\n\n        Exclusion Criteria:\n\n          -  Pregnant, breast feeding women\n\n          -  Allergy\n\n          -  Contraindication to dexamethasone\n\n          -  Contraindication to ondansetron\n\n          -  Contraindication to propofol, remifentanil, morphine, ketoprofen\n\n          -  Limit to the use of bispectral index"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01876290", 
            "org_study_id": "2012/14"
        }, 
        "intervention": [
            {
                "arm_group_label": "Dexamethasone and Ondansetron", 
                "description": "Comparison between Dexamethasone and Ondansetron and placebo in the prevention of postoperative Nausea and Vomiting", 
                "intervention_name": "Dexamethasone and Ondansetron", 
                "intervention_type": "Drug", 
                "other_name": "Dexamethasone and Ondansetron"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": "Placebo"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Dexamethasone acetate", 
                "Dexamethasone", 
                "Ondansetron", 
                "Dexamethasone 21-phosphate", 
                "BB 1101"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Anesthesiology", 
            "Complications", 
            "Closed-loop"
        ], 
        "lastchanged_date": "December 13, 2013", 
        "location": {
            "contact": {
                "email": "charmeau@offratel.nc", 
                "last_name": "Alain Charmeau, MD", 
                "phone": "687 261 866"
            }, 
            "facility": {
                "address": {
                    "city": "Noum\u00e9a", 
                    "country": "France", 
                    "zip": "98800"
                }, 
                "name": "Clinique de la Baie des Citrons"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Should we Associate Dexamethasone and Ondansetron to Closed-loop Anesthesia to Reduce the Incidence of Postoperative Nausea and Vomiting After Bariatric Surgery?", 
        "overall_contact": {
            "email": "m.fischler@hopital-foch.org", 
            "last_name": "Marc Fischler, MD", 
            "phone": "46252442", 
            "phone_ext": "00331"
        }, 
        "overall_official": {
            "affiliation": "H\u00f4pital Foch", 
            "last_name": "Marc Fischler, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Severe nausea (>  to 4 on a 0-10 visual analogue scale) or vomiting", 
            "measure": "Postoperative nausea or vomiting", 
            "safety_issue": "No", 
            "time_frame": "24 hours"
        }, 
        "reference": [
            {
                "PMID": "21233500", 
                "citation": "Liu N, Chazot T, Hamada S, Landais A, Boichut N, Dussaussoy C, Trillat B, Beydon L, Samain E, Sessler DI, Fischler M. Closed-loop coadministration of propofol and remifentanil guided by bispectral index: a randomized multicenter study. Anesth Analg. 2011 Mar;112(3):546-57. doi: 10.1213/ANE.0b013e318205680b. Epub 2011 Jan 13."
            }, 
            {
                "PMID": "21401538", 
                "citation": "Song JW, Park EY, Lee JG, Park YS, Kang BC, Shim YH. The effect of combining dexamethasone with ondansetron for nausea and vomiting associated with fentanyl-based intravenous patient-controlled analgesia. Anaesthesia. 2011 Apr;66(4):263-7. doi: 10.1111/j.1365-2044.2011.06648.x."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01876290"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "incidence of nausea with delay of occurrence and severity (0-10 visual analogue scale)", 
                "measure": "incidence of nausea", 
                "safety_issue": "No", 
                "time_frame": "one day after anesthesia"
            }, 
            {
                "description": "incidence of vomiting with delay of occurrence", 
                "measure": "incidence of vomiting", 
                "safety_issue": "No", 
                "time_frame": "one day after anesthesia"
            }, 
            {
                "description": "use of rescue treatment for PONV", 
                "measure": "rescue treatment", 
                "safety_issue": "No", 
                "time_frame": "one day after anesthesia"
            }, 
            {
                "description": "postoperative pain score (0-10 visual analogue scale)", 
                "measure": "pain", 
                "safety_issue": "No", 
                "time_frame": "one day after anesthesia"
            }, 
            {
                "description": "postoperative sedation (0-10 visual analogue scale)", 
                "measure": "sedation", 
                "safety_issue": "No", 
                "time_frame": "one day after surgery"
            }
        ], 
        "source": "Hopital Foch", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hopital Foch", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}